First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

JCM, Free Full-Text

LAA Closure

Diagnostic and Interventional Cardiology

Boston Scientific says Watchman FLX proved superior to Abbott's Amplatzer Amulet - MassDevice

Left atrial appendage occlusion in patients with atrial fibrillation: focus on current evidence and commercially available

Structural Heart Occluders

Diagnostic and Interventional Cardiology

Frontiers Left atrial appendage exclusion in atrial fibrillation

TCT DAIC

Diagnostic and Interventional Cardiology

WATCHMAN FLX™ Device - SEAL FLX Results Analysis

The Watchman FLX: the initial Polish experience with the new device for left atrial appendage occlusion.

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR